It was observed that in the group of patients with non-luminal HER2-positive cancer, the pCR rate did not depend on the age of patients, compared with patients with luminal HER2-positive cancer, of whom mainly young patients achieved pCR (Figure 1). This evidence concerns the gene ERBB2 and cancer.